Avalyn

Investment area
Venture Investments
Region
North America
Date of investment
March 2017

Avalyn is a virtual pharmaceutical company developing an improved therapy for the treatment of Idiopathic Pulmonary Fibrosis (IPF).

Avalyn

Investment area
Venture Investments
Region
North America
Date of investment
March 2017

Avalyn is a virtual pharmaceutical company developing an improved therapy for the treatment of Idiopathic Pulmonary Fibrosis (IPF).

Avalyn

Investment area
Venture Investments
Region
North America
Date of investment
March 2017

Avalyn is a virtual pharmaceutical company developing an improved therapy for the treatment of Idiopathic Pulmonary Fibrosis (IPF).